CATUG
CATUG is a boutique one-stop CRDMO empowering the global next generation therapeutics. Founded in 2021, the company is powered by approximately 200 professionals and state-of-the-art R&D and GMP facilities across Asia, the United States, and Europe. Guided by its four core “F” values — Focus, First, Fast, Flexible — CATUG delivers full-lifecycle support from R&D through global commercialization, providing comprehensive end-to-end solutions across DNA, RNA, (t)LNP, protein, and Fill & Finish (F&F). With quality and efficiency at the core, CATUG bridges cutting-edge science with robust, scalable execution to accelerate clients’ innovative therapies worldwide while ensuring uncompromising quality, regulatory compliance, and speed-to-market.
